Multidisciplinary treatment for peripheral arterial occlusive disease and the role of eHealth and mHealth

Journal of Multidisciplinary Healthcare

Volumn 5, Issue , 2012, Pages 257-263

  Fokkenrood, Hugo J P ^a,b   Lauret, Gert Jan ^a,b   Scheltinga, Marc R M ^c   Spreeuwenberg, Cor ^b   de Bie, Rob A ^b   Teijink, Joep A W ^a,b  

^a CATHARINA HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

Cost effectiveness; eHealth; Intermittent claudication; Multidisciplinary treatment

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; COST EFFECTIVENESS ANALYSIS; EMPOWERMENT; GENERAL PRACTITIONER; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; INTERDISCIPLINARY COMMUNICATION; KINESIOTHERAPY; MEDICAL INFORMATICS; MOBILE PHONE; NETHERLANDS; PATIENT REFERRAL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICIAN ATTITUDE; PHYSIOTHERAPIST; QUALITY CONTROL; REIMBURSEMENT; SOCIAL PARTICIPATION; SPECIALIZATION; WIRELESS COMMUNICATION;

EID: 84874850362     PISSN: None     EISSN: 11782390     Source Type: Journal    
DOI: 10.2147/JMDH.S35779     Document Type: Article

References (16)

1. Rapport De zorg: hoeveel extra is het ons waard? (Dutch Government Report: healthcare, how much is it worth extra?) Dutch Ministry of Health Welfare and Sports. June 12, 2012. (Dutch)
2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S: S5-S67.
3. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738-743.
4. Hirsch AT, Haskal ZJ, Hertzer NR, etal. ACC/AHA 2005 Practice Guidelines Vascular Surgery, Society for Cardiovascular Angiography and Circulation. 2006;113(11):e463-e654.
5. Lauret GJ, van Dalen DC, Willigendael EM, etal. Supervised exercise therapy for intermittent claudication: current status and future perspectives. Vascular. 2012;20(1):12-19.
6. Criqui MH. Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. Am J Cardiol. 2001;88(7B):43J-47J.
7. Criqui MH, Langer RD, Fronek A, etal. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381-386.
8. Dormandy J, Heeck L, Vig S. Predictors of early disease in the lower limbs. Semin Vasc Surg. 1999;12(2):109-117.
9. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7-22.
10. Erb W. About intermittent walking and nerve disturbances due to vascular disease [Uber das "intermitterende Hinken" und adere nervose Storungen in Folge von Gefasserkrankungen]. Deutsch Z Nervenheilk. 1898;13:1-76.
11. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008;4:CD000990.
12. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2006;19(2):CD005263.
13. Nicolai SP, Teijink JA, Prins MH; Exercise Therapy in Peripheral Arterial Disease Study Group. Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg. 2010;52(2): 348-355.
14. Bartelink M, Stoffers H, Boutens E, Hooij J, Kaiser V, Boomsma L. NHG-standaard Perifeer arterieel vaatlijden [Guideline peripheral arterial disease from the Dutch General Practioners Society]. Huisarts en Wetenschap. 2003;46:848-858.
15. Vahl AC, Reekers JC. Richtlijn diagnostiek en behandeling van arterieel vaatlijden van de onderste extremiteit. (The guideline, Diagnosis and treatment of peripheral artery disease of the lower extremities.) Ned Tijdschr Geneeskd. 2005 July 23;149(30). (Dutch)
16. Lauret GJ, van Dalen HC, Hendriks HJ, etal. When is supervised exercise therapy considered useful in peripheral arterial occlusive disease? A nationwide survey among vascular surgeons. Eur J Vasc Endovasc Surg. 2012;43(3):308-312.